4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-266437
Director acquired 1,429 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| JEFFS ROGER Director | 2026-06-08 | Option exercise | +1,429 | 58,939 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| JEFFS ROGER Director | 2026-06-08 | Option exercise · Restricted Stock Units | −1,429 | 0 | D: show line 2 in the form |
Loading xslF345X06/ownership.xml…